M&A
UK's CMA clears Microsoft's $69bn acquisition of Activision Blizzard
The UK’s Competition and Markets Authority said on Friday that it has cleared Microsoft’s proposed $69bn acquisition of 'Call of Duty' maker Activision Blizzard.
Halfords surges on takeover speculation
Halfords shares surged on Thursday after markets blog Betaville reported in one of its 'uncooked alerts’ that the motoring and cycling products retailer was at the centre of takeover speculation.
Restaurant Group to be taken over by PE firm Apollo in £701m deal
Wagamama owner The Restaurant Group said on Thursday that it has agreed to be taken over by private equity firm Apollo in a £701m deal.
UK watchdog to probe Arcelik-Whirlpool deal
The UK competition watchdog is to launch an in-depth investigation into the proposed merger of white goods manufacturers Whirlpool and Arcelik, it was confirmed on Wednesday.
Next close to snapping up FatFace in £100m deal - report
Next is reportedly close to snapping up FatFace in a deal worth more than £100m.
Apax Global Alpha makes €16.6m investment in Bazooka Candy
Investment firm Apax Global Alpha has invested approximately €16. 6m into Bazooka Candy Brands on a look-through basis.
Bodycote spends $145m to further expand US footprint
Thermal processing services group Bodycote has announced it is spending $145m on two specialist tech companies and opening a new facility to expand its reach in North America.
Aviva surges on takeover speculation
Aviva surged on Friday after markets blog Betaville suggested in one of its ‘uncooked’ alerts that the insurance group was at the centre of takeover talk.
Consortium said to table offer for Ascential events arm, shares surge
A consortium of strategic and financial investors has reportedly approached Ascential with a bid to take over its Cannes Lions and other events operations.
Superdry strikes joint venture deal with India's Reliance, shares soar
Superdry said on Wednesday that it has struck a £40m partnership deal with India’s Reliance Brands, sending shares in the struggling fashion retailer sharply higher.
Eli Lilly to buy Point Biopharma in $1.4bn deal
Eli Lilly said on Tuesday that it has agreed to buy radiopharmaceutical company Point Biopharma in a $1. 4bn cash deal.